Novartis News and Activities

Presence

Novartis develops and sells medicines for serious diseases. Its main products include prescription drugs, gene therapies, and radioligand treatments for patients, healthcare providers, and health systems worldwide.

Novartis products and services overview:

Prescription medicines
Generic medicines
Biosimilar medicines
Gene therapies
Radioligand therapies
Cancer treatments

Revenue: ~$50 billion

Employees: 76,000

Headquarters: Basel, Switzerland

Novartis is one of the...

Novartis is a company listed under the stock ticker NOVN (CH).

Novartis has a direct presence in 35 countries.

Novartis has 54 subsidiaries including Alcon, Alcon ANZ and Alcon APAC.

They are in:

Acquisition, funding and merger involving Novartis.

Novartis has acquired Avidity Biosciences (posted on March 3 2026).
Novartis has announced the acquisition of Avidity Biosciences (posted on October 27 2025).
Novartis has announced the acquisition of Tourmaline Bio (posted on September 9 2025).

Executives

View the org chart displaying its 453 main executives

Most searched biographies at Novartis

Popular executive movements at Novartis

Liz Moran has joined the company as Vice President, Talent and Development (posted on May 31 2026).
Mukul Mehta, who was Head of Business and Digital Finance and Tax, is promoted to Chief Financial Officer (posted on March 18 2026).
Charles Swanton has joined the company as Director (posted on March 13 2026).

Click here to view some more movements at Novartis

Create your alert
to follow the executive moves at Novartis.